Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson’s disease

INTRODUCTION: After several years of brain-sensing technology development and proof-of-concept studies, adaptive deep brain stimulation (aDBS) is ready to better treat Parkinson’s disease (PD) using aDBS-capable implantable pulse generators (IPGs). New aDBS devices are capable of continuous sensing...

Descripción completa

Detalles Bibliográficos
Autores principales: Marceglia, Sara, Conti, Costanza, Svanidze, Oleg, Foffani, Guglielmo, Lozano, Andres M, Moro, Elena, Volkmann, Jens, Arlotti, Mattia, Rossi, Lorenzo, Priori, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724732/
https://www.ncbi.nlm.nih.gov/pubmed/34980610
http://dx.doi.org/10.1136/bmjopen-2021-049955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724732/
https://www.ncbi.nlm.nih.gov/pubmed/34980610
http://dx.doi.org/10.1136/bmjopen-2021-049955

Ejemplares similares